Illumina's margin expansion and a coming revenue recovery should help the stock multiples re-rate toward life science ...

At this time, I would like to welcome everyone to Novanta Incorporated's Third Quarter 2024 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' ...

DNA synthesis platform developer joins de novo designer in latest of three partnerships recently launched or advanced.

“There are two ways to do MRD [testing]: by a flow cytometry study and next-generation sequencing.” He noted that instead ... This can help predict longer disease control and longer survival, he ...

With newer breast cancer treatments, it’s essential that nurses and APPs educate themselves and advocate for their patients.

Aggies Invent, hosted by Los Alamos National Laboratory, fosters student innovation in tackling critical needs within ...

KEY POINTS A 22-year-old White man presented to the emergency department with a 2-month history of progressive fatigue, intermittent abdominal pain, constipation, and dyspnea. He had gained 27 kg over ...

The Singularity South Africa Summit 2024, which took place in Johannesburg last month, in collaboration with Old Mutual, saw business titans and thought leaders ...

A collaborative study by researchers from Baylor College of Medicine and Illumina has showcased the exceptional capabilities of the DRAGEN (Dynamic Read Analysis for GENomics) platform in ...

Besides highlighting its sequencers, the company also launched a program to help researchers who want to incorporate spatial transcriptomic into their research.

Now, a method termed 2-bromoacrylamide-assisted cyclization sequencing (BACS) has been developed that enables the accurate quantification of Ψ stoichiometry, precise identification of Ψ ...

A team of biologists, environmental scientists and geneticists affiliated with multiple institutions across the U.S. has ...